Summary: Shares of CVS Health Corp have stalled around the $63.30 level, which was a peak in July, despite positive analyst comments. Understanding investor psychology around peaks and bottoms is crucial for trading decisions.
Full articleSummary: CVS Pharmacy workers in California authorize bargaining team to call for an unfair labor practice strike due to dissatisfaction with contract negotiations and alleged labor violations. CVS has made progress on tentative agreements but the union is prepared to strike if necessary.
Full articleSummary: Glenview Capital Management, a major shareholder of CVS Health, is expected to meet with top executives of CVS on Monday to propose changes and improvements to the struggling healthcare company.
Full articleSummary: Hedge fund mogul Larry Robbins to present a turnaround plan to CVS executives, aiming to boost profitability while holding significant stake in CVS. CVS shares have been declining due to lowered profit outlook and internal issues.
Full articleSummary: CVS Health Corp. plans to cut another 2,900 jobs, mostly corporate, impacting Aetna's Hartford headquarters. The layoffs are part of a $2 billion cost-cutting initiative aiming to invest in technology.
Full articleSummary: Shares of CVS Health rose after a major hedge-fund investor planned to meet with its executives to discuss operational improvements.
Full articleSummary: U.S. equities were stable on the last day of a strong September and third quarter. CVS Health shares surged on reports of potential changes, while Stellantis cut its guidance due to market weakness and Chinese competition.
Full articleSummary: Glenview Capital Management plans to meet with CVS Health Corp. to propose operational improvements, potentially leading to an activist push.
Full articleSummary: The Federal Trade Commission has sued the nation’s three biggest pharmacy benefit managers, accusing them of creating a system that has driven up the price of insulin. The PBMs, including CVS Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s Optum Rx, deny the allegations and blame insulin manufacturers for the issue.
Full articleSummary: 1. The Biden administration is taking its Cancer Moonshot Initiative global to reduce cervical cancer in the Indo-Pacific region. 2. Trump promises to 'save vaping' if reelected, praising the industry after previously pursuing a crackdown. 3. The FTC sues major pharmacy benefit managers for allegedly inflating insulin costs to gain higher rebates from drugmakers.
Full articleSummary: FTC sues UnitedHealth, Cigna, and CVS over high insulin prices due to PBMs' greed.
Full articleSummary: Oak Street Health, a subsidiary of CVS Health Inc agreed to settle for $60 million following allegations of False Claims Act violation by paying kickbacks to third-party insurance agents for patient referrals. The settlement also resolves claims brought under the whistleblower provisions of the False Claims Act by Joseph Stinson.
Full article